Cargando…

A novel cytarabine crystalline lipid prodrug: Hexadecyloxypropyl cytarabine 3′,5′-cyclic monophosphate for proliferative vitreoretinopathy

PURPOSE: The objectives of this study were to synthesize and characterize two types of cytarabine (Ara-C) lipid produgs and evaluate the prodrugs for sustained intraocular delivery after administration by intravitreal injection. METHODS: Hexadecyloxypropyl cytarabine 5′-monophosphate (HDP-P-Ara-C) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jae Suk, Beadle, James R., Freeman, William R., Hostetler, Karl Y., Hartmann, Kathrin, Valiaeva, Nadejda, Kozak, Igor, Conner, Laura, Trahan, Julissa, Aldern, Kathy A., Cheng, Lingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Vision 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413433/ https://www.ncbi.nlm.nih.gov/pubmed/22876115

Ejemplares similares

Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferation
por: Hou, Jiangping, et al.
Publicado: (2011)

A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation
por: Chen, Mei, et al.
Publicado: (2017)

Rational design of a new cytarabine-based prodrug for highly efficient oral delivery of cytarabine
por: Zhang, Jing, et al.
Publicado: (2018)

Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)
por: Lo, Michael K., et al.
Publicado: (2021)

Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)
por: Lo, Michael K., et al.
Publicado: (2021)

Cytarabine-Induced Encephalitis
por: Lenfant, Christine, et al.
Publicado: (2021)

Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
por: Ikezoe, Takayuki, et al.
Publicado: (2022)

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML
por: Malani, D, et al.
Publicado: (2017)

Cytarabine-Induced Bradycardia: A Case Report
por: Albsheer, Khalid, et al.
Publicado: (2022)

Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia
por: Zhang, Wenjun, et al.
Publicado: (2014)

Synthesis and antiviral activities of hexadecyloxypropyl prodrugs of acyclic nucleoside phosphonates containing guanine or hypoxanthine and a (S)-HPMP or PEE acyclic moiety
por: Tichý, Tomáš, et al.
Publicado: (2012)

Rethinking Remdesivir: Synthesis, Antiviral Activity and Pharmacokinetics of Oral Lipid Prodrugs
por: Schooley, Robert T., et al.
Publicado: (2021)

Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs
por: Schooley, Robert T., et al.
Publicado: (2021)

Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine
por: Kripp, Melanie, et al.
Publicado: (2008)

Hand foot syndrome associated with standard dose cytarabine
por: Sharma, Atul, et al.
Publicado: (2013)

Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine
por: Salehi, Bahare, et al.
Publicado: (2019)

Cytarabine/venetoclax: Recurrent Corynebacterium bacteraemia: case report
Publicado: (2022)

Reversible cerebral vasoconstriction syndrome after intrathecal cytarabine
por: Mendes, Natalia Trombini, et al.
Publicado: (2022)

Proliferative Vitreoretinopathy and Genetic Profile
por: Ghasemi Falavarjani, Khalil
Publicado: (2013)

Proliferative Vitreoretinopathy: A Reappraisal
por: Carpineto, Paolo, et al.
Publicado: (2023)

Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin + Cytarabine with Daunorubicin + Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia
por: Wang, Jing, et al.
Publicado: (2013)

Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia
por: Leonard, Sarah M., et al.
Publicado: (2014)

Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
por: Ersvaer, Elisabeth, et al.
Publicado: (2015)

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
por: Lancet, Jeffrey E., et al.
Publicado: (2018)

Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia
por: Momparler, Richard L
Publicado: (2013)

ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression
por: Drenberg, CD, et al.
Publicado: (2016)

Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
por: Blair, Hannah A.
Publicado: (2018)

Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia
por: Jost, Felix, et al.
Publicado: (2019)

Cytarabine/daunorubicin: Coronavirus disease-2019 pneumonia: case report
Publicado: (2021)

A sustained dual drug delivery system for proliferative vitreoretinopathy
por: Xiao, Ying, et al.
Publicado: (2020)

Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation
por: Frankiewicz, Andrzej, et al.
Publicado: (2018)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka, Ama, et al.
Publicado: (2012)

The impact of octreotide in experimental proliferative vitreoretinopathy
por: Evren, Ozge, et al.
Publicado: (2013)

Fulminant proliferative vitreoretinopathy in syphilitic uveitis
por: Queiroz, Rafael de Pinho, et al.
Publicado: (2016)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016)

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019)

Intermediate dose cytarabine improves survival and relapse-free rate compared with standard-dose cytarabine as post-remission treatment for acute myeloid leukemia: A retrospection study
por: Ye, Li, et al.
Publicado: (2021)

New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies
por: Moon, Sang Woong, et al.
Publicado: (2018)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment
por: Raut, Lalit S.
Publicado: (2015)

A desensitization protocol for delayed allergy to cytarabine: analysis of two cases
por: Albanesi, Marcello, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bffd3trq2j3g9r98t67l055e84